Amdocs EBITDA vs. Shares Outstanding
| DOX Stock | USD 87.18 0.19 0.22% |
EBITDA | First Reported 2010-12-31 | Previous Quarter 983.4 M | Current Value 629.3 M | Quarterly Volatility 218.7 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.41 | 0.3535 |
|
| |||||
| Net Profit Margin | 0.08 | 0.0996 |
|
| |||||
| Operating Profit Margin | 0.15 | 0.1338 |
|
| |||||
| Pretax Profit Margin | 0.11 | 0.12 |
|
| |||||
| Return On Assets | 0.0626 | 0.0757 |
|
| |||||
| Return On Equity | 0.0695 | 0.14 |
|
|
For Amdocs profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Amdocs to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Amdocs utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Amdocs's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Amdocs over time as well as its relative position and ranking within its peers.
Amdocs |
Is IT Consulting & Other Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.11) | Dividend Share 1.872 | Earnings Share 4.25 | Revenue Per Share 43.337 | Quarterly Revenue Growth 0.017 |
The market value of Amdocs is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amdocs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Amdocs Shares Outstanding vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Amdocs's current stock value. Our valuation model uses many indicators to compare Amdocs value to that of its competitors to determine the firm's financial worth. Amdocs is rated # 3 in ebitda category among its peers. It is rated below average in shares outstanding category among its peers creating about 0.13 of Shares Outstanding per EBITDA. The ratio of EBITDA to Shares Outstanding for Amdocs is roughly 7.44 . At this time, Amdocs' EBITDA is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amdocs' earnings, one of the primary drivers of an investment's value.Amdocs Shares Outstanding vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Amdocs |
| = | 855.15 M |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Amdocs |
| = | 115 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Amdocs Shares Outstanding Comparison
Amdocs is currently under evaluation in shares outstanding category among its peers.
Amdocs Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Amdocs, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Amdocs will eventually generate negative long term returns. The profitability progress is the general direction of Amdocs' change in net profit over the period of time. It can combine multiple indicators of Amdocs, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -47.9 M | -45.5 M | |
| Operating Income | 752.1 M | 403.8 M | |
| Income Before Tax | 731.8 M | 423 M | |
| Total Other Income Expense Net | -20.3 M | -21.3 M | |
| Net Income | 624.4 M | 350.6 M | |
| Income Tax Expense | 107.4 M | 72.5 M | |
| Net Income Applicable To Common Shares | 631.9 M | 396.4 M | |
| Net Income From Continuing Ops | 624.4 M | 531 M | |
| Interest Income | 24.4 M | 25.7 M | |
| Net Interest Income | -15.9 M | -15.1 M | |
| Change To Netincome | 55.1 M | 57.9 M | |
| Net Income Per Share | 4.14 | 4.34 | |
| Income Quality | 1.36 | 1.43 | |
| Net Income Per E B T | 0.76 | 0.58 |
Amdocs Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Amdocs. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Amdocs position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Amdocs' important profitability drivers and their relationship over time.
Use Amdocs in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amdocs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amdocs will appreciate offsetting losses from the drop in the long position's value.Amdocs Pair Trading
Amdocs Pair Trading Analysis
The ability to find closely correlated positions to Amdocs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amdocs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amdocs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amdocs to buy it.
The correlation of Amdocs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amdocs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amdocs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amdocs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Amdocs position
In addition to having Amdocs in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Non-Metallic and Industrial Metal Mining Thematic Idea Now
Non-Metallic and Industrial Metal Mining
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Non-Metallic and Industrial Metal Mining theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Non-Metallic and Industrial Metal Mining Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Amdocs Stock Analysis
When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.